New hope for Tough-to-Treat leukemia: testing a promising drug duo
Disease control
Completed
This study tested a new drug combination for adults with acute myeloid leukemia (AML), a type of blood cancer. The main goal was to find the safest and most effective dose of a new drug called liposomal annamycin when given with a standard chemotherapy drug, cytarabine. Researche…
Phase: PHASE1, PHASE2 • Sponsor: Moleculin Biotech, Inc. • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC